Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 39 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

8%

3 trials in Phase 3/4

Results Transparency

0%

0 of 14 completed trials have results

Key Signals

7 recruiting

Enrollment Performance

Analytics

N/A
17(73.9%)
Phase 2
3(13.0%)
Phase 4
2(8.7%)
Phase 3
1(4.3%)
23Total
N/A(17)
Phase 2(3)
Phase 4(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (39)

Showing 20 of 39 trials
NCT06653192Not ApplicableSuspended

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial)

Role: collaborator

NCT06375967Not ApplicableSuspended

EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)

Role: collaborator

NCT04677998Recruiting

A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis

Role: collaborator

NCT04678011Recruiting

A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy

Role: collaborator

NCT07111195Recruiting

Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)

Role: collaborator

NCT06967597Not ApplicableRecruiting

Conservative Versus Proactive Management of Acute Cholecystitis After EUS-guided Transmural Gallbladder Drainage: FUGITIVE Trial (FUGITIVE)

Role: lead

NCT04466007Phase 2Completed

Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia

Role: collaborator

NCT06899269Not Yet Recruiting

SPAROBOPAN Project (Spanish Registry of Robotic Pancreatic Surgery)

Role: lead

NCT04924868Phase 3Recruiting

Ursodeoxycolic Acid for the Prevention of Relapsing Complications After Gallstone Acute Pancreatitis

Role: lead

NCT03921502Not ApplicableRecruiting

Clinical Trial Comparing ERCP vs ERCP and Transmural Gall Bladder Drainage

Role: collaborator

NCT06409741Not ApplicableEnrolling By Invitation

PrEveNtion of Biliary Events After Acute Pancreatitis in NonSUrgicaL PAtients: PENINSULA Trial

Role: lead

NCT06375954Not ApplicableNot Yet Recruiting

EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)

Role: collaborator

NCT06375928Not ApplicableNot Yet Recruiting

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial)

Role: collaborator

NCT04595058Not ApplicableCompleted

LAMS Choledochoduodenostomies: With or Without Coaxial Plastic Stent

Role: collaborator

NCT06367322Completed

Statins and Post-ERCP Acute Pancreatitis (Stark Project)

Role: lead

NCT06351553Not ApplicableNot Yet Recruiting

Effect of the Autonomic Nervous System on the Outcomes of PULSEd Field Ablation to Treat Atrial Fibrillation

Role: lead

NCT06327672Recruiting

INOCA Spanish National Registry

Role: collaborator

NCT06076824Phase 4Unknown

Glucocorticoid Treatment in Transaortic Valve Replacement to Reduce the Incidence of Conduction Disturbances (GLUCO-TAVR).

Role: lead

NCT05689268Not ApplicableCompleted

EUS-PPG vs HVPG in Portal Hypertension

Role: lead

NCT05888753Completed

Textbook Outcome in Adrenal Neoplasms

Role: lead